CluePoints Wins Award for Best Technological Development in Clinical Trials

CluePoints, a leading provider of Centralized Statistical Monitoring (CSM) solutions for clinical trials, was honoured with the award for the 'Best Technological Development in Clinical Trials' at the 2014 Scrip Awards held at The Lancaster Hotel, London on 3 December. The award, sponsored by the MCT Congress, recognizes 'CluePoints in the Cloud' as the ultimate quality oversight and risk-based monitoring (RBM) application developed to determine the quality and integrity of clinical trials data.

With customers already able to utilise CluePoints' CSM solution as a service, the company has been continually working to enhance the usability of its platform to meet the industry’s current needs and taking into consideration the feedback from its clients. In particular the need for a solution that enables companies to take full control of their own RBM activities using all the data within their clinical databases. In response, CluePoints launched a solution to enable customers to drive their own analyses through a new web platform. Taking away the need for processes to be solely overseen by a separate organisation, the solution puts the management of RBM processes firmly in the hands of sponsors and CROs.
 

"It is an honour to receive an award that recognises the value of our CSM solution developed to empower sponsors and CROs to objectively and independently determine both the quality and integrity of their trial data", says Franҫois Torche, CEO of CluePoints. "I would like to extend continual thanks to all our customers and of course the CluePoints' team who developed this award-winning first-of-its-kind cloud-based platform."